E. Šatkutės dantų technikos laboratorija, UAB - financials and debts
Company age: 13 y. 7 mo.
E. Šatkutės dantų technikos laboratorija - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 43,928 | 72,616 | 75,511 | 39,009 | 18,607 | 22,830 | 9,090 | 7,480 |
| Profit before tax | -11,338 | 10,884 | 6,081 | -12,588 | -7,967 | -1,927 | - | - |
| Net profit | -11,338 | 10,884 | 5,797 | -12,588 | -7,967 | -1,927 | -6,799 | 649 |
| Equity | 10,120 | 21,004 | 26,801 | 3,413 | -4,554 | -6,481 | -13,280 | -12,631 |
| Liabilities | 16,774 | 6,720 | 2,977 | 3,496 | 7,601 | 10,194 | 16,587 | 16,314 |
| Non-current assets | 13,761 | 10,097 | 6,522 | 3,234 | 1,585 | 1,207 | 1,237 | 245 |
| Current assets | 13,133 | 13,984 | 23,256 | 3,675 | 1,462 | 2,506 | 2,070 | 3,438 |
| Total assets | 26,894 | 24,081 | 29,778 | 6,909 | 3,047 | 3,713 | 3,307 | 3,683 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,737 | 1,130 | 238 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -43.0% | +65.3% | +4.0% | -48.3% | -52.3% | +22.7% | -60.2% | -17.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -42.2% | 45.2% | 19.5% | -182.2% | -261.5% | -51.9% | -205.6% | 17.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -112.0% | 51.8% | 21.6% | -368.8% | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -25.8% | 15.0% | 7.7% | -32.3% | -42.8% | -8.4% | -74.8% | 8.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -25.8% | 15.0% | 8.1% | -32.3% | -42.8% | -8.4% | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.7 | 0.3 | 0.1 | 1.0 | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 21,964 | 36,308 | 37,756 | 19,505 | 9,304 | 11,415 | 5,454 | 7,480 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
E. Šatkutės dantų technikos laboratorija - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-03 | 2026-05-11 | 1.25 |
| 2026-04-24 | 2026-04-29 | 1.25 |
| 2026-01-24 | 2026-02-16 | 122.52 |
| 2026-01-16 | 2026-01-23 | 220.79 |
| 2025-10-23 | 2025-11-06 | 1.29 |
| 2025-08-31 | 2025-09-03 | 0.05 |
| 2025-08-19 | 2025-08-29 | 0.05 |
| 2025-08-06 | 2025-08-10 | 0.98 |
| 2025-07-24 | 2025-08-05 | 218.70 |
| 2025-07-16 | 2025-07-23 | 220.79 |
| 2025-06-27 | 2025-07-02 | 196.65 |
| 2025-06-17 | 2025-06-26 | 221.72 |
| 2025-06-11 | 2025-06-16 | 0.93 |
| 2025-06-08 | 2025-06-09 | 0.93 |
| 2025-05-16 | 2025-06-04 | 0.93 |
| 2025-05-04 | 2025-05-13 | 0.93 |
| 2025-04-24 | 2025-04-29 | 0.93 |
| 2025-03-18 | 2025-03-23 | 220.79 |
| 2025-01-24 | 2025-01-26 | 52.69 |
| 2025-01-22 | 2025-01-23 | 196.71 |
| 2025-01-16 | 2025-01-21 | 195.60 |
| 2024-12-22 | 2024-12-26 | 196.54 |
| 2024-12-17 | 2024-12-20 | 196.54 |
| 2024-11-18 | 2024-11-25 | 197.48 |
| 2024-10-24 | 2024-11-17 | 0.94 |
| 2024-08-19 | 2024-08-26 | 294.66 |
E. Šatkutės dantų technikos laboratorija - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-04-02 | 2025-04-09 | 0.96 |
| 2025-03-06 | 2025-04-01 | 0.66 |
| 2025-03-02 | 2025-03-05 | 215.34 |
| 2025-02-26 | 2025-03-01 | 215.16 |
| 2025-02-20 | 2025-02-25 | 239.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
E. Šatkutes dantu technikos laboratorija, UAB (code 302985350) is a Private Limited Liability Company operating in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the company generated EUR 7.5K in revenue and EUR 649 in net profit, compared with a net loss in both 2023 and 2024. Revenue declined from EUR 22.8K in 2023 to EUR 9.1K in 2024 and then to EUR 7.5K in 2025, which means a 17.7% year-on-year drop and a 67.2% decrease over two years. Profitability improved materially in 2025 after losses of EUR 1.9K in 2023 and EUR 6.8K in 2024, resulting in an 8.7% profit margin. At year-end 2025, total assets stood at EUR 3.7K, equity remained negative at EUR 12.6K, and liabilities were EUR 16.3K. Asset turnover was 2.03x, while revenue per employee was EUR 7.5K and profit per employee was EUR 649. The negative equity level shows that the balance sheet remained under pressure despite the return to profit.